Spyre Therapeutics, Inc. (SYRE) Earnings
NASDAQ·Healthcare·Biotechnology
$98.40
-1.56%
Mkt Cap $6.20B
EPS — Estimate vs Actual
Mkt Cap
$6.20B
P/E
—
Fwd P/E
—
P/S
68.55
Rev TTM
—
EPS TTM
-$2.19
NASDAQ·Healthcare·Biotechnology
$98.40
-1.56%
Mkt Cap $6.20B
Mkt Cap
$6.20B
P/E
—
Fwd P/E
—
P/S
68.55
Rev TTM
—
EPS TTM
-$2.19